Corrective Action & Preventive Action in the pharma industry is more than a regulatory and standardization requirement. It is applied to all critical components of the pharma industry as a problem-solving technique and helps to prevent them in the future. CAPA also serves regulatory requirements for the pharma industries in most major markets, such as the United States and the EU.
CAPA is an essential element of the pharma quality system. It is applied across all departments and functions of the pharma industry to implement, track, verify, and document the effectiveness of corrective and preventive actions.
What is a CAPA?
CAPA is a technique to improve the existing process, system, and practices by studying the root cause of the failures and taking necessary steps to prevent them from occurring in the future. The CAPA system also intends to solve the current problem by proposing corrective actions to make the system operational until appropriate preventive actions are devised and implemented.
The overall purpose of a CAPA is to prevent problems and failures that a pharma organization routinely faces. Examples include product recalls or equipment breakdowns, which have a significant impact on the quality of the pharma process quality, and can also create compliance issues.
With CAPA, a pharma organization has a defined system of communicating preventive and corrective actions to relevant responsible departments or personnel and can be tracked for system improvement and follow-up. Traditional communication systems, such as email or verbal communication, do not have any regulatory authority or significance and are prone to errors and other shortcomings.
It is necessary to record CAPA in a documented form for better implementation and to present it to the regulatory body during the routine inspection. The format of CAPA can take varying forms, but it should contain all the relevant information.
Acceptance criteria are also part of CAPA implementation, which is used to verify the CAPA result.
Importance of CAPA
Many factors make the CAPA an important element of the pharma quality system, and some of them include the following.
Information collection
CAPA allows for collecting information about the product or system's error or failure. Information collection is the hardest part of the problem-solving process, often affected by various factors such as failure to understand a system, lack of resources & mindset. All these factors make the information collection process difficult and erratic.
CAPA allows pharma organizations to collect information accurately whenever a problem arises. It also enables the collection of information scientifically with proper resources and at a fixed frequency.
The information collected through CAPA can be used to implement various corrective and preventive actions, considerable investment, and changes in existing systems throughout a specific department or an entire pharma manufacturing facility.
Investigation
CAPA enables a pharma organization to investigate problems by utilizing the information collected. The CAPA includes the detailed study of information gathered by personnel with expertise in their field and applying different methodologies, tools, and thought processes. It enables investigators to understand complex systems and connect all the dots.
Without a proper CAPA, the investigation lacks the following attributes
● Irregular investigative cycle, i.e. for an incident, sometimes an investigation is conducted, while for other incident investigation is completely neglected.
● Difficult to understand real-world problems being faced a pharma organization, and at the same time total failure to understand complex systems for accurate reasoning and evolvement.
● Failure or inability to allocate dedicated resources such as personal and tools, resulting in wasting them
The shortcomings mentioned above, and like these, can affect the investigation process, which ultimately involves preventive actions.
Resultant actions
The CAPA allows the pharmaceutical organization to take accurate corrective and preventive actions base...
(All Rights Reserved)